Quick Answer
INOVIO PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 69.00 million shares for the year ending 2025.
- INOVIO PHARMACEUTICALS, INC. showed an increase of +91.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from INOVIO PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), INOVIO PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has declined by 34.3%.
- Historical annual values: Fiscal year 2025: 69.00 million shares | Fiscal year 2024: 36.10 million shares | Fiscal year 2023: 22.79 million shares | Fiscal year 2022: 21.09 million shares | Fiscal year 2021: 217.38 million shares | Fiscal year 2020: 186.85 million shares | Fiscal year 2019: 101.36 million shares | Fiscal year 2018: 97.23 million shares | Fiscal year 2017: 90.36 million shares | Fiscal year 2016: 74.06 million shares | Fiscal year 2015: 72.22 million shares | Fiscal year 2014: 60.74 million shares | Fiscal year 2013: 52.58 million shares | Fiscal year 2012: 144.31 million shares | Fiscal year 2011: 134.97 million shares | Fiscal year 2010: 105.04 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: